Bladder, Kidney and Prostate Cancer Clinical Trials and Research

Norton Cancer Institute is at the forefront of cancer treatment research. As principal investigators on numerous trials, our specialist physicians have access to innovative treatments and numerous bladder cancer, urothelial cancer and genitourinary cancer clinical trials and studies.

Learn more about participating in a clinical trial at Norton Healthcare.

Current Clinical Trials and Studies

Current Bladder, Kidney, Prostate and other Genitourinary Cancer Published Research from Norton Cancer Institute Physicians

Recurrence Rates for Pediatric Benign Ovarian Neoplasms
Safety and efficacy of first-line nivolumab plus ipilimumab alternating with nivolumab monotherapy in patients with advanced renal cell carcinoma: the non-randomised, open-label, phase IIIb/IV CheckMate 920 trial
Failure of Operative Therapy after Ovarian-Sparing Surgery for Pediatric Benign Ovarian Neoplasms: A Retrospective Review
Phase II trial of CV301 vaccine combined with atezolizumab in advanced urothelial carcinoma
Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA Trial

Bladder, Kidney and Prostate Cancer Clinical Trials and Research

Bladder, Kidney and Prostate Cancer Clinical Trials and Research

Current Clinical Trials and Studies

Current Bladder, Kidney, Prostate and other Genitourinary Cancer Published Research from Norton Cancer Institute Physicians

Related Stories

Cancer care medical assistant celebrates the past, looks forward to the future during Black History Month

Does HPV cause throat cancer?

How to prevent cervical cancer

Smoking causes cancer, no matter how many years you’ve been doing it

Schedule an Appointment